Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Jun-18 5:00 PM View:  | Koven Andrew I President & Chief Business Off | Aralez Pharmaceuticals Inc. (ARLZ) | 04-Jun-18 | Market Sale (Planned) | 156,573 | $0.37 | $58,589.60 | (12%) 1.34M to 1.18M | 92% |
| 16-May-18 7:50 PM View: | Koven Andrew I President & Chief Business Off | Aralez Pharmaceuticals Inc. (ARLZ) | 14-May-18 | Market Sale (Planned) | 13,964 | $0.52 | $7,261.28 | (1%) 1.35M to 1.34M | 95% |
| 16-May-18 7:49 PM View: | Tursi James Patrick Chief Medical Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 14-May-18 | Market Sale (Planned) | 9,348 | $0.52 | $4,881.53 | (4%) 251.4K to 242.05K | 95% |
| 21-Mar-18 5:16 PM View: | Tursi James Patrick Chief Medical Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 19-Mar-18 | Market Sale (Planned) | 5,950 | $1.70 | $10,115.00 | (2%) 257.35K to 251.4K | 98% |
| 21-Mar-18 5:15 PM View: | Glickman Mark A Chief Commercial Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 19-Mar-18 | Market Sale (Planned) | 5,725 | $1.70 | $9,732.50 | (2%) 255.91K to 250.19K | 98% |
| 21-Mar-18 5:16 PM View: | Trachtenberg Eric GC, CCO & Secretary | Aralez Pharmaceuticals Inc. (ARLZ) | 19-Mar-18 | Market Sale (Planned) | 3,471 | $1.70 | $5,900.70 | (2%) 201.56K to 198.09K | 98% |
| 21-Mar-18 5:16 PM View: | Koven Andrew I President & Chief Business Off | Aralez Pharmaceuticals Inc. (ARLZ) | 19-Mar-18 | Market Sale (Planned) | 9,739 | $1.70 | $16,556.30 | (< 1%) 1.36M to 1.35M | 98% |
| 19-Mar-18 8:30 PM View: | Kaseta Michael Chief Financial Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-18 | Grant | 12,500 | -- | -- | 500% 2.5K to 15.0K | |
| 12-Dec-17 7:00 AM View: | Kirsch Arthur S Director | Aralez Pharmaceuticals Inc. (ARLZ) | 08-Dec-17 | Market Purchase | 50,000 | $1.47 | $73,535.00 | 22% 226.61K to 276.61K | (98%) |
| 04-Oct-17 8:32 PM View: | Tursi James Patrick Chief Medical Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 02-Oct-17 | Market Sale (Planned) | 9,960 | $2.50 | $24,917.90 | (4%) 267.31K to 257.35K | 99% |
| 28-Jul-17 7:00 PM View: | Charles Scott J Chief Financial Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 28-Jul-17 | Market Sale (Planned) | 10,804 | $1.25 | $13,509.30 | (4%) 291.36K to 280.55K | 98% |
| 23-Jun-17 5:20 PM View: | Trachtenberg Eric GC, CCO & Secretary | Aralez Pharmaceuticals Inc. (ARLZ) | 23-Jun-17 | Market Sale (Planned) | 7,720 | $1.33 | $10,267.60 | (4%) 209.28K to 201.56K | 98% |
| 19-Jun-17 7:00 AM View: | Kirsch Arthur S Director | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Jun-17 | Market Purchase | 15,000 | $1.15 | $17,181.00 | 7% 211.61K to 226.61K | (98%) |
| 16-Jun-17 7:01 AM View: | Kirsch Arthur S Director | Aralez Pharmaceuticals Inc. (ARLZ) | 14-Jun-17 | Market Purchase | 50,000 | $1.17 | $58,525.00 | 31% 161.61K to 211.61K | (98%) |
| 06-Jun-17 8:28 PM View: | Koven Andrew I President & Chief Business Off | Aralez Pharmaceuticals Inc. (ARLZ) | 05-Jun-17 | Market Sale | 161,906 | $1.28 | $207,110.00 | (11%) 1.53M to 1.36M | 98% |
| 24-May-17 6:07 AM View: | Aryeh Jason Director | Aralez Pharmaceuticals Inc. (ARLZ) | 23-May-17 | Market Sale | 104,176 | $1.41 | $146,878.00 | (87%) 119.18K to 15.0K | 98% |
| 24-May-17 6:07 AM View: | Aryeh Jason Director | Aralez Pharmaceuticals Inc. (ARLZ) | 22-May-17 | Market Sale | 233,468 | $1.42 | $332,365.00 | (66%) 352.64K to 119.18K | 98% |
| 24-May-17 6:07 AM View: | Aryeh Jason Director | Aralez Pharmaceuticals Inc. (ARLZ) | 19-May-17 | Market Sale | 51,041 | $1.56 | $79,557.60 | (13%) 403.69K to 352.64K | 98% |
| 12-May-17 9:52 PM View: | Tursi James Patrick Chief Medical Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 83,192 | -- | -- | 45% 184.12K to 267.31K | |
| 12-May-17 9:52 PM View: | Koven Andrew I President & CBO | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 109,190 | -- | -- | 8% 1.42M to 1.53M | |
| 12-May-17 9:50 PM View: | Aryeh Jason Director | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 7,500 | -- | -- | 2% 350.72K to 358.22K | |
| 12-May-17 9:54 PM View: | Charles Scott J Chief Financial Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 83,192 | -- | -- | 40% 208.16K to 291.36K | |
| 12-May-17 9:51 PM View: | Harris Robert Paul Director | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 7,500 | -- | -- | < 1% 1.19M to 1.2M | |
| 12-May-17 9:51 PM View: | Rudnick Seth Director | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 7,500 | -- | -- | 7% 109.39K to 116.89K | |
| 12-May-17 9:52 PM View: | Glickman Mark A Chief Commercial Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 80,163 | -- | -- | 46% 175.75K to 255.91K | |
| 12-May-17 9:53 PM View: | Adams Adrian Chief Executive Officer Director | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 218,380 | -- | -- | 6% 3.57M to 3.79M | |
| 12-May-17 9:50 PM View: | Fowler Neal Franklin Director | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 7,500 | -- | -- | 11% 66.37K to 73.87K | |
| 12-May-17 9:55 PM View: | Armstrong Jennifer Lou EVP HR and Administration | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 45,096 | -- | -- | 40% 111.73K to 156.82K | |
| 12-May-17 9:52 PM View: | Thrasher Francis Martin Director | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 7,500 | -- | -- | 3% 284.68K to 292.18K | |
| 12-May-17 9:50 PM View: | Kirsch Arthur S Director | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 7,500 | -- | -- | 5% 154.11K to 161.61K | |
| 12-May-17 9:53 PM View: | Trachtenberg Eric GC, CCO & Secretary | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 64,784 | -- | -- | 45% 144.5K to 209.28K | |
| 12-May-17 9:51 PM View: | Lee Kenneth B Jr Director | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 7,500 | -- | -- | 8% 95.45K to 102.95K | |
| 22-Mar-17 4:18 PM View: | Charles Scott J Chief Financial Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 20-Mar-17 | Market Sale (Planned) | 5,205 | $2.41 | $12,544.10 | (2%) 213.37K to 208.16K | 99% |
| 22-Mar-17 4:17 PM View: | Koven Andrew I President & Chief Business Off | Aralez Pharmaceuticals Inc. (ARLZ) | 20-Mar-17 | Market Sale (Planned) | 7,825 | $2.41 | $18,858.20 | (< 1%) 1.42M to 1.42M | 99% |
| 17-Mar-17 4:16 PM View: | Adams Adrian Chief Executive Officer Director | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-17 | Market Purchase | 500,000 | $2.46 | $1,230,950.00 | 16% 3.07M to 3.57M | (99%) |
| 17-Mar-17 4:17 PM View: | Koven Andrew I President & Chief Business Off | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-17 | Market Purchase | 20,000 | $2.55 | $50,920.00 | 1% 1.4M to 1.42M | (99%) |
| 17-Mar-17 4:16 PM View: | Kirsch Arthur S Director | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-17 | Market Purchase | 45,000 | $2.27 | $102,249.00 | 41% 109.11K to 154.11K | (99%) |
| 17-Mar-17 4:16 PM View: | Tursi James Patrick Chief Medical Officer | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-17 | Market Purchase | 4,750 | $2.11 | $10,022.50 | 3% 179.37K to 184.12K | (99%) |
| 17-Mar-17 4:17 PM View: | Lee Kenneth B Jr Director | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-17 | Market Purchase | 5,000 | $2.52 | $12,618.50 | 6% 90.45K to 95.45K | (99%) |
| 17-Mar-17 4:17 PM View: | Rudnick Seth Director | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-17 | Market Purchase | 15,000 | $2.26 | $33,949.50 | 16% 94.39K to 109.39K | (99%) |
| 30-Nov-16 7:56 PM View: | Harris Robert Paul Director | Aralez Pharmaceuticals Inc. (ARLZ) | 29-Nov-16 | Option Exercise | 104,778 | $3.92 | $410,730.00 | 9% 1.19M to 1.3M | |
| 30-Nov-16 7:56 PM View: | Harris Robert Paul Director | Aralez Pharmaceuticals Inc. (ARLZ) | 29-Nov-16 | Market Option Sale | 104,778 | $4.99 | $523,146.00 | (8%) 1.3M to 1.19M | 99% |
| 30-Nov-16 7:56 PM View: | Harris Robert Paul Director | Aralez Pharmaceuticals Inc. (ARLZ) | 28-Nov-16 | Option Exercise | 20,000 | $3.92 | $78,400.00 | 2% 1.19M to 1.21M | |
| 30-Nov-16 7:56 PM View: | Harris Robert Paul Director | Aralez Pharmaceuticals Inc. (ARLZ) | 28-Nov-16 | Market Option Sale | 20,000 | $4.65 | $93,000.00 | (2%) 1.21M to 1.19M | 99% |
| 12-Dec-16 8:50 PM View: | Rudnick Seth Director | Aralez Pharmaceuticals Inc. (ARLZ) | 23-Nov-16 | Gift | 30,000 | -- | -- | 32% 94.39K to 124.39K | |
| 12-Dec-16 8:50 PM View: | Rudnick Seth Director | Aralez Pharmaceuticals Inc. (ARLZ) | 23-Nov-16 | Gift | 30,000 | -- | -- | (24%) 124.39K to 94.39K | |
| 15-Nov-16 5:43 PM View: | Lee Kenneth B Jr Director | Aralez Pharmaceuticals Inc. (ARLZ) | 14-Nov-16 | Market Purchase | 1,000 | $4.95 | $4,950.00 | 1% 89.45K to 90.45K | (99%) |
| 15-Nov-16 5:44 PM View: | Rudnick Seth Director | Aralez Pharmaceuticals Inc. (ARLZ) | 11-Nov-16 | Market Purchase | 30,000 | $4.77 | $143,121.00 | 47% 64.39K to 94.39K | (99%) |
| 25-Apr-17 4:30 PM View: | Aryeh Jason Director | Aralez Pharmaceuticals Inc. (ARLZ) | 16-Sep-16 | Market Purchase | 295,929 | $5.86 | $1,732,660.00 | 540% 54.79K to 350.72K | (100%) |
| 19-Sep-16 7:57 PM View: | Harris Robert Paul Director | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Sep-16 | Market Sale | 150,000 | $5.82 | $873,218.00 | (11%) 1.34M to 1.19M | 100% |
